"Corporate Structure, Indirect Bankruptcy Costs, and the Advantage of De ..."

M. Lourdes Sosa (2014)

> Home

Details and statistics

DOI: 10.1287/ORSC.2013.0876

access: closed

type: Journal Article

metadata version: 2020-07-16

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/orgsci/Sosa14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/orgsci/Sosa14
M. Lourdes Sosa:
Corporate Structure, Indirect Bankruptcy Costs, and the Advantage of De Novo Firms: The Case of Gene Therapy Research. Organ. Sci. 25(3): 850-867 (2014)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.